The Peptide Directory

Not approved (research only)Copper-binding tripeptideSkinRecovery

GHK-Cu

Not FDA-approved as a drug; widely used as a cosmetic ingredient in topical products.

Last reviewed by The Peptide Directory Editorial Team

What is GHK-Cu?

GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, which occurs naturally in human plasma; it is used in topical cosmetics and has been studied for skin and tissue repair, but it is not an FDA-approved drug.

Key takeaways

  1. Naturally present in plasma; levels decline with age according to published reviews.
  2. Most consumer use is topical (serums, creams).
  3. Injectable use is not approved.

Structure

2D chemical structure of GHK-Cu (C14H21CuN6O4-), as depicted by PubChem
Structure: PubChem CID 139035031 (C14H21CuN6O4-, 400.9 g/mol). 2D depiction from NCBI PubChem, retrieved October 19, 2026.

What makes GHK-Cu different?

GHK-Cu is one of the few peptides with a long cosmetic history; topical cosmetic use is regulated differently from injectable drug use.

How does GHK-Cu work?

Reviews report that GHK-Cu influences collagen and glycosaminoglycan synthesis, antioxidant responses and the expression of many genes in experimental systems.

What the clinical evidence actually shows

  • A 2012 review (Oxid Med Cell Longev) summarizes gene-expression and tissue-remodeling findings, mostly from laboratory and animal work.

How much research exists on GHK-Cu?

PubMed indexes 83 papers mentioning GHK-Cu in the title or abstract, 51 of them from the last five years and 1 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

Registered clinical studies

ClinicalTrials.gov lists 3 studies with GHK-Cu as an intervention (see all). Most recent:

Side effects

Topical cosmetic use is generally well tolerated in published reports; injectable use lacks controlled human safety data.

Regulatory & access status

  • Not an FDA-approved drug. Present in cosmetic products.

Sourcing & safety

Cosmetic products are sold openly; injectable "research" GHK-Cu is not for human use.

Doses in labels and trials

Reference only — copied from published research. Not a recommendation.

SourceWhat it says
Human doseNo approved injectable dose exists. Cosmetic products use varying topical concentrations.

What the evidence does not show

  • Systemic anti-aging effects in humans.
  • Safety of injecting research-grade product.

GHK-Cu FAQ

What is GHK-Cu?

A copper complex of the tripeptide glycine-histidine-lysine that occurs naturally in human plasma and is used in topical cosmetics.

Is GHK-Cu FDA-approved?

No, not as a drug. It is used as a cosmetic ingredient.

Related peptides & comparisons

BPC-157TB-500 Injury & Recovery

References

  1. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging, Oxid Med Cell Longev (2012), PMID 22666519
  2. GHK-Cu — PubChem compound summary (CID 139035031), PubChem

GHK-Cu calculators

Lab arithmetic only: convert a mass to a volume or syringe units at a known concentration with the units converter, or work out a concentration with the reconstitution calculator.

There is no FDA-approved GHK-Cu product. Compounded versions depend on FDA's compounding rules, and "research use only" products are not for human use.

Get GHK-Cu via telehealth

None of the telehealth providers we have verified lists GHK-Cu.

Research suppliers that list GHK-Cu

43 vendors in our directory listed a product matching GHK-Cu in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.

Prices per mg, where we could verify them, are on our price comparison.

GHK-Cu dosing protocol

There is no FDA-label or published-trial dosing schedule we can reproduce for GHK-Cu, so we don't publish one.

Find clinics offering GHK-Cu

47 verified clinics name GHK-Cu; browse them by state.

Browse all clinics